Pcas SA
PAR:PCA
Relative Value
There is not enough data to reliably calculate the relative value of PCA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PCA Competitors Multiples
Pcas SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Pcas SA
PAR:PCA
|
109.9m EUR | 0.5 | 12.5 | -188.7 | -6.7 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 364 | 4 310.7 | 1 366.8 | 2 920.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
192.9B USD | 4.3 | 28.8 | 20.1 | 27 | |
| US |
|
Danaher Corp
NYSE:DHR
|
144.8B USD | 5.9 | 40.1 | 20.3 | 29.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 15 | 51.6 | 30.3 | 40.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.2B CHF | 5.6 | 38.3 | 28.3 | 28.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
262.2B CNY | 5.9 | 17.5 | 17.5 | 17.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.1B USD | 4.8 | 26.5 | 20.8 | 24.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
31.2B USD | 9.8 | 48.5 | 31.3 | 39.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
30B USD | 1.8 | 22.2 | 12.2 | 18.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.5B USD | 6.6 | 30.4 | 22.5 | 25 |